TIMP2 and cancer: The inhibitory effect of TIMP-2-specific inhibition on MMP-2 (previous findings show a strong balance between MMP-2 and TIMP-2 in the case of cancer cells [33]) can explain the observed lack of TIMP-2 overexpression in PsA patient plasma.